Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies

NCT03385668 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Fibrosis

Interventions

DRUG: Pirfenidone

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]